Concepedia

Dennis M. Grasela

DM

77

Publications

7.2K

Citations

38

H-Index

1984

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Michigan

University of Colorado Denver

Bristol-Myers Squibb (Sweden)

Dennis M. Grasela is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and virology.

Top concepts

Publications per year

1984–2023

77

Publications

77

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 929 citations · Full text

, , +10

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Anna S. Lok, David Gardiner, Eric Lawitz et al. · New England Journal of Medicine · 2012 · 607 citations · Full text

Pharmacodynamics of Fluoroquinolones against <i>Streptococcus pneumoniae</i> in Patients with Community-Acquired Respiratory Tract Infections

Paul G. Ambrose, Dennis M. Grasela, Thaddeus H. Grasela et al. · Antimicrobial Agents and Chemotherapy · 2001 · 297 citations · Full text

, , +19

A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection

David Gardiner, Jay Lalezari, Eric Lawitz et al. · PLoS ONE · 2013 · 227 citations · Full text

Rows per page

1–5 of 77